| Literature DB >> 35057220 |
Liangliang Yue1,2, Haolan Li1, Qi Sun3, Xiaogang Luo1,4, Fengshou Wu1, Xunjin Zhu2.
Abstract
Cancer is one of the major diseases threatening human health. Traditional cancer treatments have notable side-effects as they can damage the immune system. Recently, phototherapy, as a potential strategy for clinical cancer therapy, has received wide attention due to its minimal invasiveness and high efficiency. Herein, a small organic molecule (PTA) with a D-A-D structure was prepared via a Sonogashira coupling reaction between the electron-withdrawing dibromo-perylenediimide and electron-donating 4-ethynyl-N,N-diphenylaniline. The amphiphilic organic molecule was then transformed into nanoparticles (PTA-NPs) through the self-assembling method. Upon laser irradiation at 635 nm, PTA-NPs displayed a high photothermal conversion efficiency (PCE = 43%) together with efficient reactive oxygen species (ROS) generation. The fluorescence images also indicated the production of ROS in cancer cells with PTA-NPs. In addition, the biocompatibility and photocytotoxicity of PTA-NPs were evaluated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and live/dead cell co-staining test. Therefore, the as-prepared organic nanomaterials were demonstrated as promising nanomaterials for cancer phototherapy in the clinic.Entities:
Keywords: organic nanomaterials; perylene diimide; photothermal therapy; reactive oxygen species; self-assembly
Year: 2022 PMID: 35057220 PMCID: PMC8781609 DOI: 10.3390/ma15020502
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Comparison of different organic nanomaterials for PTT.
| Nanomaterials | Type | Size | Absorption | PCE | Reference |
|---|---|---|---|---|---|
| PDI-NPs | Small molecule | 55 nm | 630 nm | 43% | [ |
| ZnP2 NPs | Small molecule | 120 nm | 668 nm | 33.4% | [ |
| BAF4 NPs | Small molecule | 79 nm | 1000 nm | 80% | [ |
| NDTB NPs | Small molecule | 110 nm | 1050 nm | 40.6% | [ |
| PTA-NPs | Small molecule | 200 nm | 800 nm | 43% | This work |
Scheme 1The synthetic routes of PTA and PTA-NPs.
Figure 1(A) TEM image of PTA-NPs; (B) DLS size profiles of PTA-NPs; (C) zeta potential of PTA-NPs; (D) UV/Vis absorption spectra of PTA and PTA-NPs (insert: the photographs of PTA in THF and PTA-NPs in PBS); (E) fluorescence spectra of PTA, PDI, TPA, and PTA-NPs; (F) changes in photoluminescence (PL) intensity of the characteristic peak of DCF (525 nm) with irradiation time.
Figure 2(A) Photothermal curves of PTA-NPs (45 μg/mL) under irradiation of 635 nm laser at different power densities; (B) photothermal curves of PTA-NPs at different concentration under 635 nm laser irradiation (1.25 W/cm2); (C) photothermal stability of PTA-NPs (45 μg/mL) during five on/off cycles of laser (1.25 W/cm2); (D) photothermal effect of PTA-NPs in water under irradiation of 635 nm laser (1.25 W/cm2) for 10 min, followed by the cooling for 10 min; (E) negative logarithmic relationship between cooling time and temperature; (F) photothermal images of different concentrations of PTA-NPs under 635 nm laser (1.25 W/cm2) irradiation (top: images of PTA-NP solution under natural light; bottom: thermal images after 635 nm laser irradiation for 10 min).
Figure 3(A) Concentration dependence of the cytotoxicity of PTA-NPs against A549 cells; (B) fluorescence images of calcein AM (green fluorescence; live cells) and PI (red fluorescence; dead cells) co-stained A549 cells after treated with PBS only, laser irradiation only, PTA-NPs only, or PTA-NPs + laser irradiation (scale bar = 25 μm); (C) the intracellular ROS generation of PTA-NPs using DCFH-DA as a fluorescent probe (scale bar = 25 μm).